Long-term care pharmacy leaders call for COVID-19 relief from Congress
McKnight’s Senior Living
Kimberly Bonvissuto– July 14, 2020
Leaders from 12 of the nation’s largest long-term care pharmacies sent a letter to leaders in Congress on Friday asking for $350 million in financial relief to meet challenges presented by the COVID-19 pandemic.
Members of the Senior Care Pharmacy Coalition, which represents 75% of the long-term care pharmacy sector, cited significant revenue losses and higher costs due to the pandemic in serving assisted living communities, nursing homes and other communal settings where older adults live.
“Due to the pandemic, LTC pharmacy revenues have dropped 25% while costs increased 6% from March to May,” the letter reads, citing unplanned costs for additional personal protective equipment, employee support and medication supplies, as well as higher delivery expenses. “Without financial relief, residents in nursing homes and assisted living facilities may face interruptions in access to essential, life-saving medications.”
The requested $350 million in relief represents 2% of long-term care pharmacy annual patient care revenues of $17.5 billion, which is the benchmark relief percentage the U.S. Department of Health and Human Services established for other providers, the organization said.
SCPC President and CEO Alan Rosenbloom said that policymakers have provided $4.9 billion in COVID-19 Medicare relief funds for nursing homes and $15 billion in funds for Medicaid providers, and that HHS is working on relief for assisted living providers, but long-term care pharmacies — which he called the “essential behind-the-scenes partner” — largely have been ignored.
He also said HHS created new obstacles to relief for LTC pharmacies in June by excluding prescription sales from patient revenues and disproportionately limited relief compared with other provider types.
Long-term care pharmacies “cannot be silent about the outsized impacts the pandemic has had on our sector and our need for immediate relief to fulfill this nation’s promise to our most vulnerable citizens,” the letter said.
About 2 million Americans in long-term care facilities rely on long-term care pharmacies to manage and deliver 12 to 13 different medications daily to each resident, according to SCPC.
“The financial situation for long-term care pharmacies mirrors the financial situation for nursing homes and assisted living facilities,” Rosenbloom said. “Congress must address this issue promptly to ensure LTC pharmacies have access to the relief they need. The absence of this timely, consistent pharmacy support from LTC pharmacies would make the dire circumstances LTC facilities continue to work through much worse.”
Companies represented on the letter were PharmcareUSA, Guardian Pharmacy Services, PharMerica, NHS Management, Consonus, Forum Extended Care Services, M Chest Institutional Pharmacy Group, HealthDirect Institutional Pharmacy Services, PharmScript, Remedi SeniorCare and PCA Pharmacy.
Recent Posts
-
Senior Care Pharmacy Coalition Applauds Chairman Comer and House Oversight Committee for Shedding Light on Harmful PBM Practices, Encourages Congress to Advance PBM Reform Legislation Heard Today in House Energy and Commerce Committee Health Subcommittee
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the House Oversight Committee’s hearing on pharmacy benefit managers.
-
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay in the long-term, experts warned this week. The Centers for Medicare & Medicaid Services on Tuesday announced the first 10 drugs covered by Medicare Part D that will be included in negotiations running through 2024. They are all commonly prescribed drugs that treat conditions ranging from diabetes to arthritis and heart failure.
-
Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector. As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.